Amarin Corp Plcuk (AMRN) EBIT Margin (2013 - 2026)

Amarin Corp Plcuk (AMRN) reported EBIT Margin of 25.11% for Q1 2026, up 1476.0% year-over-year from 1.59% in Q1 2025, and down 135.48% quarter-over-quarter from 70.77% in Q4 2025.

Amarin Corp Plcuk (AMRN) EBIT Margin (2013 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 14 years of EBIT Margin data on file, last reported at 25.11% in Q1 2026.

  • EBIT Margin for Q1 2026 came in at 25.11%, up 1476.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.66% (up 884.0% YoY), and the FY2025 annual result was 4.22%, up 422.0% from the prior year.
  • EBIT Margin slipped to 25.11% in Q1 2026 per AMRN's latest filing, from 70.77% in the prior quarter.
  • Over five years, EBIT Margin peaked at 70.77% in Q4 2025 and troughed at 66.53% in Q2 2022.
  • A 5-year average of 12.95% and a median of 22.35% in 2025 frame the typical range for EBIT Margin.
  • The sharpest annual moves came in 2022 and 2023: EBIT Margin tumbled 7221 bps in 2022, then jumped 7665 bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 10.62% in 2022, then surged by 722 bps to 66.03% in 2023, then plunged by 51 bps to 32.06% in 2024, then jumped by 121 bps to 70.77% in 2025, then sank by 135 bps to 25.11% in 2026.
  • Business Quant data shows AMRN's EBIT Margin at 25.11% in Q1 2026, 70.77% in Q4 2025, and 22.35% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 30.06%
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 47.98%
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 26.44%
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 26.60%
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -47.46%
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 30.94%
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 37.16%
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -286.83%
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -1.58%
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn -25.11%

Historic Data

Download Data
DateValue
Mar 31, 2026 -25.11%
Dec 31, 2025 70.77%
Sep 30, 2025 -22.35%
Jun 30, 2025 -21.98%
Mar 31, 2025 -39.88%
Dec 31, 2024 32.06%
Sep 30, 2024 -59.50%
Jun 30, 2024 -0.78%
Mar 31, 2024 -24.03%
Dec 31, 2023 66.03%
Sep 30, 2023 -32.47%
Jun 30, 2023 -29.89%
Mar 31, 2023 -20.17%
Dec 31, 2022 -10.62%
Sep 30, 2022 -5.72%
Jun 30, 2022 -66.53%
Mar 31, 2022 -29.91%
Dec 31, 2021 5.85%
Sep 30, 2021 -9.20%
Jun 30, 2021 5.68%